In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel
Last month, Justin and Amy Miller packed their vehicles with three kids, two dogs, a pet...
A respiratory virus that doesn’t have a vaccine or a specific treatment regimen is spreading...
